Has William Weily, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $11,168 in general payments to William Weily, DPM across 404 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Weily, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Weily, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Weily, DPM

Podiatrist · Charlotte, NCNPI 1912197146

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,446 of the $11,168 with a category attached, or 84.6%. It is spread thinly across 37 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Among podiatrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,168in general payments, 2019–2025

Across 404 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organogenesis Inc.$3K
Amgen$2K
Mid-atlantic Surgical Systems, LLC$1K
Smith+Nephew$1K
Abbott$900
Treace Medical Concepts, Inc.$887
plus $3K from 31 others

What the payments were for

Speaking & faculty fees$1041%
Travel & lodging$4194%
Food & beverage$9,44685%
Education$1,20011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organogenesis Inc.	110	$2,679
Amgen(2 entities)	57	$1,506
Mid-atlantic Surgical Systems, LLC	1	$1,200
Smith+Nephew	68	$1,093
Abbott	41	$900
Treace Medical Concepts, Inc.	11	$887
Paratek Pharmaceuticals, Inc.	39	$739
Stryker	4	$234
Bard Peripheral Vascular, Inc.	2	$204
Kerecis Limited	2	$186
ANI Pharmaceuticals, Inc.	3	$170
Medtronic	1	$150
Osiris Therapeutics Inc.	11	$148
Bioventus LLC	9	$148
GRT US Holding, Inc.	6	$126
Reapplix Inc.	1	$94
Convatec Inc.	5	$92
Johnson & Johnson	2	$58
Merck	4	$54
Nevro Corp.	2	$48
Kowa Pharmaceuticals America, Inc.	3	$47
Integra Lifesciences Corporation	2	$46
Tactile Systems Technology Inc	2	$42
Globus Medical	1	$40
Cashflow Solutions, LLC	2	$40
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$34
KCI USA, Inc.	2	$33
Vertex	1	$31
ETS Wound Care LLC	2	$26
Nabriva Therapeutics, PLC	1	$24
Averitas Pharma Inc.	1	$23
Melinta Therapeutics, LLC	1	$15
Axogen	1	$13
Pfizer	1	$13
AbbVie	1	$12
Orthofix Medical, Inc.	1	$10
Advanced Oxygen Therapy Inc.	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,168 in reported general payments places this provider in the 95th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina →

Medicare billing

Part B allowed, 2024

$131,147

Medicare patients

436

Services billed

2,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	120	$4,670
Mupirocin	155	$1,146
Ammonium Lactate	32	$739
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	26	$632
Clotrimazole	23	$526
Doxycycline Hyclate	48	$475
Clindamycin Hcl	45	$371
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	40	$369
Ciclopirox	14	$262
Gabapentin	16	$196
Silver Sulfadiazine	13	$125
SsdSilver Sulfadiazine	16	$117
Pregabalin	13	$112

Paid to pharmacies, not to this prescriber.

Other podiatrist in Charlotte

Richard LindCharlotte$8K
Nicholas MillerCharlotte$4K
Thomas WhitfieldCharlotte$3K
Kinjal PatelCharlotte$3K
Jordan MeyersRaleigh$343K
Christopher GaulandGreenville$56K
Scott MartinRocky Mount$14K
Gretchen LawrenceForest City$12K
Kristin KirbyHuntersville$10K
Robert PrzynoschWaynesville$9K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →